Dr. Meuse has pioneered a multitude of minimally-invasive endovascular techniques and devices in Charlotte since arriving in 2010 and consistently brings the most cutting edge therapies to his patients.  He has been involved in global research trials with investigational devices in the peripheral vascular space, including drug-eluting stent technology, atherectomy devices and intravascular lithotripsy balloon angioplasty.  He is a national thought leader with vascular limb preservation therapies and has developed a premier amputation-prevention service line in the community treating patients with critical limb ischemia (CLI).  He was the first in Charlotte to perform pedal and alternative access procedures in the treatment of peripheral arterial disease (PAD), and was the first to utilize drug-coated balloon angioplasty and bioresorpable tibial artery stent technology.  He has expertise in the minimally invasive treatments of aneurysms, endoleak embolization, visceral atherosclerotic stenosis and stent placement, fibromuscular dysplasia and renal artery balloon angioplasty, pelvic congestion and gonadal vein embolization, deep venous thrombosis (DVT) and venous thrombectomy, May-Thurner syndrome and iliac venous stenting, portal vein interventions such as TIPS and BRTO, pulmonary embolism (PE) and pulmonary thrombectomy, acute stroke thrombectomy, uterine fibroids and uterine artery embolization (UAE), acute vertebral compression fractures and vertebroplasty/kyphoplasty.  Dr. Meuse works closely with referring specialists to ensure evidence-based care that maximizes the best achievable patient outcomes and prioritizes patient well-being.